title: Thalidomide use and digital gangrene.
authors.affiliation: Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA.
authors.forename: Tyler Y
authors.initials: TY
authors.lastname: Kang
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Lowe
authors.forename: Mikkael A
authors.initials: MA
authors.lastname: Sekeres
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects; D002908:Chronic Disease; D003646:Debridement; D005260:Female; D005385:Fingers / Q000098:blood supply* / Q000601:surgery; D005734:Gangrene / Q000139:chemically induced* / Q000601:surgery; D006801:Humans; D008875:Middle Aged; D055728:Primary Myelofibrosis / Q000188:drug therapy; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D013792:Thalidomide